{
    "eid": "2-s2.0-85046681387",
    "title": "Prognostic value of plasma EBV DNA for nasopharyngeal cancer patients during treatment with intensity-modulated radiation therapy and concurrent chemotherapy",
    "cover-date": "2018-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Radiology, Nuclear Medicine and Imaging",
            "@code": "2741",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "IMRT",
        "nasopharyngeal cancer",
        "plasma EBV",
        "Prognosis during treatment"
    ],
    "authors": [
        "Chawalit Lertbutsayanukul",
        "Danita Kannarunimit",
        "Anussara Prayongrat",
        "Chakkapong Chakkabat",
        "Sarin Kitpanit",
        "Pokrath Hansasuta"
    ],
    "citedby-count": 13,
    "ref-count": 26,
    "ref-list": [
        "The clinical utility of plasma Epstein-Barr virus DNA assays in nasopharyngeal carcinoma: The dawn of a new era?: A systematic review and meta-analysis of 7836 cases",
        "Analysis of plasma Epstein-Barr Virus DNA to screen for nasopharyngeal cancer",
        "Prognostic impact of plasma Epstein-Barr Virus DNA in patients with nasopharyngeal carcinoma treated using intensity-modulated radiation therapy",
        "Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma",
        "Plasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinoma",
        "High-sensitivity C-reactive protein complements plasma Epstein-Barr virus deoxyribonucleic acid prognostication in nasopharyngeal carcinoma: A large-scale retrospective and prospective cohort study",
        "Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma",
        "Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma",
        "Circulating pre-treatment Epstein-Barr virus DNA as prognostic factor in locally-advanced nasopharyngeal cancer in a non-endemic area",
        "Pretreatment Epstein-Barr virus DNA load and cumulative cisplatin dose intensity affect long-term outcome of nasopharyngeal carcinoma treated with concurrent chemotherapy: Experience of an institute in an endemic area",
        "Plasma EBV DNA clearance rate as a novel prognostic marker for metastatic/recurrent nasopharyngeal carcinoma",
        "Prevalence and significance of plasma Epstein-Barr Virus DNA level in nasopharyngeal carcinoma",
        "Different clinical significance of pre-and post-treatment plasma Epstein-Barr virus DNA load in nasopharyngeal carcinoma treated with radiotherapy",
        "Prognostication of serial post-intensity-modulated radiation therapy undetectable plasma EBV DNA for nasopharyngeal carcinoma",
        "Metronomic adjuvant chemotherapy improves treatment outcome in nasopharyngeal carcinoma patients with postradiation persistently detectable plasma Epstein-Barr virus deoxyribonucleic acid",
        "Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099",
        "Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety",
        "Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs. Radiotherapy alone for regionally advanced nasopharyngeal carcinoma",
        "Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase 3 multicentre randomised controlled trial",
        "Kinetics of plasma Epstein-Barr virus DNA during radiation therapy for nasopharyngeal carcinoma",
        "Plasma Epstein-Barr viral DNA load at midpoint of radiotherapy course predicts outcome in advanced-stage nasopharyngeal carcinoma",
        "A randomized phase II/III study of adverse events between sequential (SEQ) versus simultaneous integrated boost (SIB) intensity modulated radiation therapy (IMRT) in nasopharyngeal carcinoma; Preliminary result on acute adverse events",
        "Prognostic role of plasma Epstein-Barr virus DNA load for nasopharyngeal carcinoma: A meta-analysis",
        "A randomized phase III study between sequential versus simultaneous integrated boost intensity-modulated radiation therapy in nasopharyngeal carcinoma",
        "Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensitymodulated radiotherapy alone",
        "Treatment outcomes after radiotherapy alone for patients with early-stage nasopharyngeal carcinoma"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "funding": []
}